Product Information

ZOLMITRIPTAN 2.5 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.0074 per EA under NDC 68462049776. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on May 14, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZOLMITRIPTAN 2.5 MG TABLET

Zolmitriptan
$1.0074per EA

Strength

2.5 mg/1

NDC

68462049776

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ZOLMITRIPTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA201779

FDA Approved

5/14/2013

TE Code

AB

On Market Since

5/14/2013

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for ZOLMITRIPTAN 2.5 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 86.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0074 per EA
All-time high$8.4908 (Apr 16, 2014)
All-time low$0.7713 (May 22, 2024)
52-week high$1.1116
52-week low$0.9324
Median price$1.5732
Average price$3.7771
Largest weekly change-78.2% (Feb 19, 2020)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+8.1%

1M

-1.5%

3M

-0.3%

6M

-9.4%

1Y

-5.5%

3Y

+10.2%

5Y

-20.4%

All

-86.6%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ZOLMITRIPTAN 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 2.5 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.0074 per EA (NDC 68462049776), effective Nov 18, 2026.

How has the price of ZOLMITRIPTAN 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZOLMITRIPTAN 2.5 MG TABLET has declined 86.6%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 2.5 MG TABLET?

Since Nov 28, 2013, the NADAC for ZOLMITRIPTAN 2.5 MG TABLET has ranged from a low of $0.7713 (May 22, 2024) to a high of $8.4908 (Apr 16, 2014), with a median of $1.5732 per EA.

Are there cheaper alternatives to ZOLMITRIPTAN 2.5 MG TABLET?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZOLMITRIPTAN 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ZOLMITRIPTAN 2.5 MG TABLET?

ZOLMITRIPTAN 2.5 MG TABLET (NDC 68462049776) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.